Edgen Stock·Dec 11 2025, 19:51Back
Roivant Details Multi-Asset Growth Strategy
Edgen Stock·Dec 11 2025, 19:51
[1] Nuvalent Appoints Ron Squarer to Board of Directors – Company Announcement - Financial Times (https://markets.ft.com/data/announce/detail?d ...)[2] Pfizer Enters into Exclusive Collaboration and License Agreement with YaoPharma - BioSpace (https://www.biospace.com/press-releases/pfize ...)[3] Phanes Therapeutics to Present Phase 1/2 Study Results of Spevatamig (PT886) in Combination with Chemotherapy in Frontline (1L) Treatment of Metastatic PDAC at ASCO GI 2026 - BioSpace (https://www.biospace.com/press-releases/phane ...)
